Agreement: Page 2

QuantuMDx inks distribution agreement with Menarini
According to the agreement, Menarini will handle the distribution and marketing of the Q-POC platform, COVID assay, and QuantuMDx’s SARS-CoV-2/Flu A/B/RSV Respiratory Panel test in the U.K. and France.
November 2, 2022
Global Collaboration Business Social
Shineco moves into point-of-care testing, inks stock purchase agreement with Chinese biotech
The stock purchase agreement is an initiative in Shineco’s strategy aimed at moving into the point-of-care testing industry.
October 25, 2022
Business Handshake Man Social
Fujirebio Europe secures distribution rights for Self-Screen's methylation-specific molecular assay
The test identifies women at high risk by detecting elevated methylation levels of cancer biomarkers, Fujirebio said, adding that it has been validated for both physician sample collection and sample self-collection.
October 11, 2022
Squamous Epithelial Cells Cervical
T2 Biosystems inks distribution agreement in Baltic region
Under the terms of the agreement, the company will sell T2Dx Instruments, along with T2Bacteria, T2Candida, and T2Resistance panels, through an undisclosed distributor.
September 22, 2022
2020 06 19 20 57 0712 Sepsis Bacteria 400
Leuko nabs $5M for validation of WBC monitoring technology
HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors provided the funding, Leuko said. The funding will allow the company to accelerate clinical trials with the aim of obtaining regulatory approval in collaboration with leading cancer centers, including the MD Anderson Cancer Center and Boston Medical Center in the U.S., and Dexeus and Hospital 12 de Octubre in Spain.
September 22, 2022
2021 01 08 22 20 9120 Cancer Cell Target2 400
Virax Biolabs inks distribution agreement for monkeypox kits
Under the agreement, Cosmos will have exclusive distribution rights for Greece and Cyprus and can distribute the kits across Europe on a nonexclusive basis.
September 21, 2022
2019 04 24 17 43 1766 Hands Shaking2 400
S2 Genomics inks distribution agreement with Proteigene
The partnership will expand the system's product line, leveraging Proteigene's customer-centric sales force and customer base, according to S2.
September 20, 2022
2020 01 08 21 29 8936 Dna Sequencing Sanger 400
Precipio announces agreement to promote HemeScreen platform
The distributor focuses on a segment of the healthcare business which by Precipio's estimates represents an additional $100 million of market potential that its current distributors are less likely to reach.
September 15, 2022
2019 04 24 17 43 1766 Hands Shaking2 400
Lee Health partners with Quest to implement lab strategy
Under the agreement, the partners aim to enhance the quality and value of diagnostic services to patients and their doctors.
September 14, 2022
2020 03 25 23 27 0591 Hands Shaking Deal 400
Qiagen, Neuron23 to develop CDx for Parkinson’s
Under the agreement, Qiagen will develop and validate a clinical trial assay that will detect a combination of biomarkers discovered by Neuron23 that together predict the responsiveness of Parkinson's disease to a LRRK2 inhibitor.
September 13, 2022
2020 07 07 21 02 7380 Parkinsons Definition 400
Quest partners with Hound Labs on cannabis testing
The deal establishes Quest as the exclusive provider of laboratory services for confirmatory testing, which will be done using its novel mass spectrometry technique.
September 13, 2022
2019 08 02 18 28 8245 Cannabis Marijuana 400
Lunaphore, Nucleai to provide AI-based spatial biology analysis
Combining Lunaphore's Comet hyperplex staining and imaging platform, a fully automated sequential immunofluorescence (seqIF) instrument, with Nucleai's Atom artificial-intelligence (AI) spatial biology platform will enable the companies to generate new insights from tissue biopsies and provide labs with an integrated end-to-end spatial biology workflow.
September 8, 2022
2022 09 09 16 29 7140 Computer Head 400
Previous Page
Page 2 of 16
Next Page